Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-09-18
2007-09-18
Le, Long V. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C435S007950, C530S387100, C436S514000
Reexamination Certificate
active
10886561
ABSTRACT:
The invention is a method for detecting squalene in sera.
REFERENCES:
patent: 5419904 (1995-05-01), Irie
patent: 5419921 (1995-05-01), Molacek et al.
patent: 5709879 (1998-01-01), Barchfeld et al.
patent: 6166050 (2000-12-01), Lombardo et al.
patent: 6191108 (2001-02-01), Rodkey et al.
patent: 6214566 (2001-04-01), Asa et al.
patent: WO95/00146 (1995-01-01), None
patent: WO98/20137 (1998-05-01), None
Chan et al. (GAO Gulf War Illness report 1999, Mar. released).
Tenebaum et al. (Lancet 1997 vol. 349, p. 449-54).
Fung et al., “3, 4-dicarboxylic Acid (A-87049): A Novel Potent Squalene Synthase Inhibitor,” Journal of Medicinal Chemistry. 1997, vol. 40, No. 14, pp. 2123-2125.
Hanley et al., “Solubilization, Partial Purification, and Immunodetection of Squalene Synthetase from Tobacco Cell Suspension Cultures,” Plant Physiology, 1992, vol. 98, No. 1, pp. 215-220.
Ryder, N.S. et al, “Interaction of terbinafine with human serum and serum proteins,” Journal of Medical and Veterinary Mycology, 1992, vol. 30, pp. 451-460.
Aggarwal, B.B. et al., “Human Lymphotoxin: Production by a Lymphoblastoid Cell Line, Purification, and Initial Characterization”, Journal of Biological Chemistry, 1984, vol. 259, No. 1, pp. 686-691.
Alving, C.R., “Natural Antibodies Against Phospholipids and Liposomes in Humans”, Biochem. Society Transactions, 1984, vol. 12, No. 2, pp. 342-344.
Alving, C.R. et al., “Naturally Occurring Autoantibodies to Cholesterol in Humans”, Biochemical Society Transactions, 1989, vol. 17, No. 4, pp. 637-639.
Alving, C.R. et al., “Preparation and Use of Liposomes in Immunological Studies”. In: G. Gregoriadis (Ed.) Liposome Technology, vol. 3 (Second Ed.), CRC Press, Inc. Boca Raton, 1993, pp. 317-343.
Alving, C.R. et al., “Antibodies to Cholesterol, Cholesterol Conjugates, and Liposomes: Implications for Atherosclerosis and Autoimmunity”, Critical Review in Immunology, 1991, vol. 10, No. 5, pp. 441-453.
Alving, C.R. et al., “Naturally Occurring Antibodies to Cholesterol: A New Theory of LDL Cholesterol Metabolism”, Immunology Today, 1999, vol. 20, No. 8, pp. 362-366.
Alving, C.R. et al., “Antibodies to Cholesterol: Biological Implications of Antibodies to Lipids”, Current Topics Microbiology Immunology, 1996, vol. 210, pp. 181-186.
Alving et al., “Immunization with Cholesterol-Rich Liposomes Induces Anti-Cholesterol Antibodies and Reduces Diet-Induced Hypercholesterolemia and Plaque Formation”, J. Lab. Clin. Med., 1996, vol. 127, No. 1, pp. 40-49.
Alving, C.R. et al., Letters to the Editor, Exp. Mol. Pathol., 2000, vol. 68, pp. 196-198.
Asa, P. et al., “Antibodies to Squalene in Gulf War Syndrome”, Exp. Mol. Pathol., 2000, vol. 68, No. 1, pp. 55-64.
Asa, P.B. et al., “Antibodies to Squalene in Recipients of Anthrax Vaccine”, Exp. Mol. Pathol., 2002, vol. 73, No. 1, pp. 19-27.
Aniagolu, J. et al., “Analysis of Anticholesterol Antibodies Using Hydrophobic Membranes”, J. Immunol. Meth., 1995, vol. 182, No. 1, pp. 85-92.
Banerji, B. et al, “Anti-Liposome Antibodies Induced By Lipid A. I. Influences of Ceramide, Glycosphingolipids, and Phosphocholine on Complement Damage”, J. Immunol., 1981, vol. 126, No. 3, pp. 1080-1084.
Beaumont, V. et al., “Antiestrogen Antobodies, Oral Contraception and Systemic Lupus Erythematosus”, Clin. Physiol. Biochem., 1989, vol. 7, pp. 263-368.
Brochu, M. et al., “Monoclonal Antibodies for Use With 125-Iodine-Labeled Radioligands in Progesterone Radioimmunoassay”, J. Steroid Biochem., 1984, vol. 21, No. 4, pp. 405-411.
Bucala, R. et al., “Anti-oestrogen Antibodies in Users of Oral Contraceptives and in Patients with Systemic Lupus Erythamatosus”, Clin. Exp. Immunol., 1987, vol. 67, No. 1, pp. 167-175.
Counihan, K.A., et al., “Anti-estrogen Antibodies in Systemic Lupus Erythematosus: A Quantitative Evaluation of Serum Levels”, Immuno. Invest., 1991, vol. 20, No. 3, pp. 317-331.
Cunningham, C.K. et al., “Safety of 2 Recombinant Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Vaccines in Neonates born to HIV-1-Infected Women”, Clin. Infect. Dis., 2001, vol. 32, No. 5, pp. 801-807.
Dijkstra, J. et al., “Interaction of Anti-Cholesterol Antibodies with Human Lipoproteins”, J. Immunol., 1996, vol. 157, No. 5, pp. 2006-2013.
Dörsam, H. “Antibodies to Steroids From A Small Human Naive IgM Library”, FEBS Lett., 1997, vol. 414, No. 1, pp. 7-13.
Drulak, M.W. et al., “Vaccination of Serpositive Subjects With CHIRON CMV gB Subunit Vaccine Combined With MF59 Adjuvant for Production of CMV Immune Globulin”, Viral Immunol., 2000, vol. 13, No. 1, pp. 49-56.
Fahey, J.L. et al., “Proliferation and Differentiation of Lymphoid Cells: Studies With Human Lymphoid Cell Lines and Immunoglobulin Synthesis”, Ann. N.Y. Acad. Sci., 1971, vol. 190, pp. 221-234.
Fantl, V.E. et al., Simultaneous Production of Monoclonal Antibodies to Dehydroepiandresterone, Oestradiol, Progesterone and Testosterone, J. Endocrinol., 1984, vol. 100, No. 3, pp. 367-376.
Franek, M., “Structural Aspects of Steroid-Antibody Specificity”, J. Steroid Biochem., 1987, vol. 28, No. 1, pp. 95-108.
Fulco, C.E., et al., “Gulf War and Health: Depleted Uranium, Pyridostigmine Bromide, Sarin, Vaccines”, National Academy Press, Washington, DC, 2000, vol. 1, p. 307.
Galfré, G. et al., “Preparation of Monoclonal Antibodies: Strategies and Procedures”, Methods Enzymol., 1981, vol. 73, (Pt.B), pp. 3-46.
Gasparini, R. et al., “Increased Immunogenicity of the MF-59-adjuvanted Influenza Vaccine Compared to a Conventional Subunit Vaccine in Elderly Subjects”, Eur. J. Epidemiol., 2001, vol. 17, No. 2, pp. 135-140.
Gigliotti, F., et al., “Reproducible Production of Protective Human Monoclonal Antibodies by Fusion of Peripheral Blood Lymphocytes with A Mouse Myeloma Cell Line”, J. Infect. Dis., 1984, vol. 149, No. 1, pp. 43-47.
Granner, D.K., “Hormones of the Adrenal Cortex”, In: R.K. Murray, et al. (Eds.) Harper's Biochemistry, 24thEdition, Appleton & Lang, Stamsord, p. 547-559
Grover, P.K. et al., “Specificity of Antisera to Sex Steroids I—The Effect of Substitution and Sterochemistry”, J. Steroid Biochem., 1977, vol. 8, No. 2, pp. 121-126.
Gupta, R.K. et al., “Adjuvant Properties of Non-Phospholipid Liposomes (Novasomes®) in Experimental Animals for Human Vaccine Antigens”, Vaccine, 1996, vol. 14, No. 3, pp. 219-225.
Harro, C.D. et al., “Safety and Immunogenicity Trial in Adult Volunteers of Human Papillomavirus 16 L1 Virus-Like Particle Vaccine”, J. Natl. Cancer Inst., 2001, vol. 93, No. 4, pp. 284-292.
Heineman, T.C. et al., “A Randomized, Controlled Study in Adults of the Immunogenicity of A Novel Hepatitis B Vaccine Containing MF59 Adjuvant”, Vaccine, 1999, vol. 17, No. 22, pp. 2769-2778.
Kahn, J.O. et al., “Clinical and Immunologic Responses to Human Immunodeficiency Virus (HIV) Type 1SF2gp120 Subunit Vaccine Combined With MF59 Adjuvant With or Without Muramyl Tripeptide Dipalmitoyl Phosphatidylethanolamine in Non-HIV-Infected Human Volunteers”, J. Infect. Dis., 1994, vol. 170, No. 5, pp. 1288-1291.
Kester, K.E. et al., “Efficacy of Recombinant Circumsporozite Protein Vaccine Regimens Against ExperimentalPlasmodium falciparumMalaria”, J. Infect. Dis., 2001, vol. 183, No. 4, pp. 640-647.
Köhler, G. et al., “Continuous Cultures of Fused Cells Secreting Antibody of Predefined Specificity”, Nature, 1975, vol. 256, No. 5517, pp. 495-497.
Koivisto, P.V. et al., “Increased Amounts of Cholesterol Precursors in Lipoproteins After Ileal Exclusion”, Lipids, 1988, vol. 23, No. 10, pp. 993-996.
Kuwahara, A. et al., “Autoantibody Against Testosterone In A Woman With Hypergonado
Alving Carl R
Matyas Gary R
Rao Mangala
Wassef Nabila M
Arwine Elizabeth
Cheu Jacob
Le Long V.
United States of America as Represented by the Secretary of the
LandOfFree
Detection of antibodies to squalene in serum does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Detection of antibodies to squalene in serum, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Detection of antibodies to squalene in serum will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3774163